Earnings
Treace Targets A $700 Million Market Expansion While Lower-Priced Products Weigh On Revenue
Management expects fourth-quarter growth as surgeons adopt a wider portfolio, with only incremental additions to the sales force.
Treace Medical Concepts (TMCI) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Earnings
Management expects fourth-quarter growth as surgeons adopt a wider portfolio, with only incremental additions to the sales force.
SEC Filings
The bunion-surgery device maker narrowed its 2026 revenue range to $206 million to $210 million and now sees a smaller adjusted loss.